• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Genentech

Genentech

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

    Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

  2. Theodore F. Craver, Jr. Joins Federal Reserve Bank of San Francisco’s Economic Advisory Council

    Theodore F. Craver, Jr. Joins Federal Reserve Bank of San Francisco’s Economic Advisory Council

  3. Across the Country, Great Strides Are Underway to Find a Cure for Cystic Fibrosis

    Across the Country, Great Strides Are Underway to Find a Cure for Cystic Fibrosis

  4. OMT Therapeutics Announces UniRat™ Alliance with Caltech

    OMT Therapeutics Announces UniRat™ Alliance with Caltech

  5. Research and Markets: Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025

    Research and Markets: Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025

  6. WaferGen Bio-systems Reports Results for First Quarter 2015

    WaferGen Bio-systems Reports Results for First Quarter 2015

  7. Ascendis Pharma A/S to Report First Quarter 2015 Financial Results and Host Conference Call on May 18, 2015

    Ascendis Pharma A/S to Report First Quarter 2015 Financial Results and Host Conference Call on May 18, 2015

  8. Ignyta Announces First Quarter 2015 Company Highlights and Financial Results

    Ignyta Announces First Quarter 2015 Company Highlights and Financial Results

  9. WaferGen Bio-systems Appoints Life Sciences Industry Veteran, Rolland D. Carlson, Ph.D., President & CEO

    WaferGen Bio-systems Appoints Life Sciences Industry Veteran, Rolland D. Carlson, Ph.D., President & CEO

  10. Roche Receives FDA Approval for cobas® KRAS Mutation Test

    Roche Receives FDA Approval for cobas® KRAS Mutation Test

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.